List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Virogin Company

They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Headquarters: Shenzhen, Guangdong, China
Investment Stage: Venture
Founded Date: 2015
Employee Number: Undisclosed
Investor Type: Undisclosed
Industry: Drug Discovery
Technology: Drug Design
Number Of Exists: 1
Funding Status: N/A